PDC-E2 inhibitors constitute a diverse class of chemicals designed to modulate the activity of PDC-E2, a protein involved in mitochondrial processes and bile acid metabolism. While direct inhibitors targeting PDC-E2 specifically are limited, several compounds indirectly influence PDC-E2 by targeting pathways associated with its regulation. NorUDCA, Ursodeoxycholic acid, OCA, GW4064, and Cholic acid impact PDC-E2 indirectly by modulating bile acid homeostasis, influencing cellular processes related to mitochondrial function and PDC-E2 activity. Bezafibrate and Pioglitazone, PPAR agonists, potentially modulate PDC-E2 through the activation of PPARs, affecting metabolism and cellular processes associated with PDC-E2 regulation.
4-Phenylbutyric acid and Resveratrol indirectly modulate PDC-E2 by influencing endoplasmic reticulum stress responses and activating SIRT1, respectively. Carnitine and L-Carnitine, involved in fatty acid metabolism and mitochondrial function, may impact PDC-E2 indirectly through their roles in cellular energy metabolism. TUDCA, a bile acid derivative, might influence PDC-E2 by affecting bile acid homeostasis and cellular processes related to its expression and function. In summary, the intricate interplay between these chemicals and PDC-E2 provides valuable insights into potential strategies for modulating PDC-E2-related cellular processes, shedding light on the complex regulatory mechanisms governing this critical mitochondrial protein.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
24-Nor Ursodeoxycholic Acid | 99697-24-2 | sc-478796 | 1 mg | $401.00 | ||
NorUDCA is a bile acid derivative that potentially modulates PDC-E2 indirectly. Bile acids are involved in the regulation of PDC-E2 expression and function, impacting mitochondrial processes related to PDC-E2 activity. | ||||||
Bezafibrate | 41859-67-0 | sc-204650B sc-204650 sc-204650A sc-204650C | 500 mg 1 g 5 g 10 g | $31.00 $46.00 $122.00 $204.00 | 5 | |
Bezafibrate, a PPAR agonist, potentially modulates PDC-E2 indirectly through the activation of PPARs. This activation influences cellular processes related to metabolism, potentially impacting the regulation of PDC-E2. | ||||||
Ursodeoxycholic acid | 128-13-2 | sc-204935 sc-204935A | 1 g 5 g | $52.00 $131.00 | 4 | |
Ursodeoxycholic acid is a bile acid that might influence PDC-E2 indirectly by affecting bile acid homeostasis. It could impact the regulation of PDC-E2 expression and function through cellular processes associated with bile acid metabolism. | ||||||
GW 4064 | 278779-30-9 | sc-218577 | 5 mg | $95.00 | 13 | |
GW4064, an FXR agonist, potentially modulates PDC-E2 indirectly through FXR activation. Activation of FXR influences bile acid homeostasis and cellular processes associated with mitochondrial function, impacting the regulation of PDC-E2. | ||||||
4-Phenylbutyric acid | 1821-12-1 | sc-232961 sc-232961A sc-232961B | 25 g 100 g 500 g | $53.00 $136.00 $418.00 | 10 | |
4-Phenylbutyric acid might indirectly modulate PDC-E2 by influencing endoplasmic reticulum stress responses. The impact on cellular pathways related to stress responses could affect the expression and function of PDC-E2. | ||||||
L-Carnitine | 541-15-1 | sc-205727 sc-205727A sc-205727B sc-205727C | 1 g 5 g 100 g 250 g | $23.00 $34.00 $79.00 $179.00 | 3 | |
Carnitine is involved in fatty acid metabolism and mitochondrial function, potentially influencing PDC-E2 indirectly. Its role in cellular processes related to energy metabolism could impact the regulation of PDC-E2. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Pioglitazone, a PPAR agonist, may modulate PDC-E2 indirectly through the activation of PPARs. This activation influences cellular processes related to metabolism, potentially impacting the regulation of PDC-E2. | ||||||
Cholic acid | 81-25-4 | sc-255020 sc-255020A sc-255020B sc-255020C sc-255020D | 25 g 100 g 500 g 1 kg 5 kg | $49.00 $123.00 $578.00 $1018.00 $4570.00 | 11 | |
Cholic acid, a primary bile acid, could influence PDC-E2 indirectly by impacting bile acid homeostasis. Cellular processes related to bile acid metabolism might play a role in the regulation of PDC-E2 expression and function. | ||||||
Tauroursodeoxycholic Acid, Sodium Salt | 14605-22-2 | sc-281165 | 1 g | $644.00 | 5 | |
TUDCA, a bile acid derivative, might influence PDC-E2 indirectly by affecting bile acid homeostasis. Cellular processes related to bile acid metabolism could play a role in the regulation of PDC-E2 expression and function. | ||||||